Tag: Evolut Low Risk trial
ACC.25: Evolut Low Risk trial shows comparable rates of all-cause mortality and stroke with TAVI and surgery at five years
Latest data from the Evolut Low Risk trial demonstrate a numerically lower rate of all-cause mor...
Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR
John Forrest (New Haven, USA) sits down with Cardiovascular News to talk about the full two-yea...
